MONTGOMERY, Ala. – Alabama Attorney General Steve Marshall on Monday, Nov. 10, announced that the Cullman County Circuit Court granted his request for a temporary restraining order against Aurora IV and Wellness, a Cullman-based IV infusion clinic, and its owners, Amanda and Chris Medders.
According to Marshall’s Office, “the defendants are accused of illegally administering unsafe, research-grade weight loss drugs to patients without their knowledge or consent.” Marshall sought a temporary restraining order to immediately close the business and freeze its assets, citing violations of Alabama’s Deceptive Trade Practices Act and serious threats to public health and safety.
Cullman County Circuit Court Judge Greg Nicholas signed the order, which includes an asset freeze, on Thursday, Nov. 6. A preliminary injunction hearing is scheduled for Nov. 13.
The complaint alleges that Aurora IV and Wellness advertised popular weight loss drugs, tirzepatide and semaglutide, as “pharmaceutical-grade.” In reality, Marshall said, “the defendants were injecting patients with research-grade versions of those drugs that are not approved for human use. The drugs’ manufacturer explicitly states that they are sold for laboratory research purposes only and should not be used by humans or animals.”
A Tribune review of the business’ website found the following language on Nov. 10:
“Semaglutide/Tirzepatide
“Price varies by dose
“Achieve your weight loss goals with these powerful, pharmaceutical grade peptides.”
Marshall said in a media release, “President Trump took decisive action to make GLP-1 weight-loss medications affordable and accessible to all Americans, ensuring that when prescribed responsibly and administered appropriately, these drugs can be an invaluable resource. By contrast, exploiting that demand by misrepresenting unapproved, research-only chemicals as legitimate medicine is one of the most dangerous forms of consumer deception imaginable.”
Marshall continued, “Patients who relied on this clinic were unknowingly injected with substances labeled strictly for research use, materials federal regulators have explicitly warned are risky for human use. This kind of reckless disregard for patient safety will not be tolerated in Alabama.”
The temporary restraining order prevents the defendants from operating while the court reviews the matter. Marshall seeks to permanently bar the defendants from working in Alabama’s healthcare industry, dissolve the company, impose civil penalties and obtain restitution for affected consumers.
The complaint alleges the defendants’ conduct began as early as May 2025. To identify affected consumers, Marshall has set up an online survey for patients who received tirzepatide or semaglutide from the defendants since that time. The survey can be accessed at www.alabamaag.gov/consumer-questionnaires.
Marshall thanked the Alabama Board of Nursing, the Alabama Board of Medical Examiners, the Cullman Police Department and the Winston County Sheriff’s Office for their assistance in the investigation and execution of the temporary restraining order.
Aurora IV and Wellness is located at 219 Compass Way SW, in Cullman.
